Yeliz Demir
Overview
Explore the profile of Yeliz Demir including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
107
Citations
766
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Abul N, Demir Y, Oztekin A, Ozdemir H
Cell Biochem Biophys
. 2025 Mar;
PMID: 40080351
Myeloperoxidase (MPO) is a highly abundant hemoprotein in neutrophils and monocytes. It has a crucial function in immunological surveillance and the body's defensive systems. Nevertheless, there is a strong correlation...
2.
Kalay E, Adem S, Demir Y, Aslan O, Sahin E, Eyupoglu V, et al.
Arch Biochem Biophys
. 2025 Mar;
768:110368.
PMID: 40049269
In this paper, a series of novel hydrazones derived from L-phenyl alanine were synthesized in four steps and employed to inhibit α-glucosidase through kinetic studies, molecular docking, and molecular dynamics...
3.
Zor M, Saglamtas R, Demirci A, Ceyran E, Fettahoglu K, Demir Y
Chem Biodivers
. 2025 Jan;
e202402802.
PMID: 39744888
Research on natural antioxidants derived from plants has surged due to their potential health benefits. In the current study, the chemical composition, enzyme inhibitory activity, and antimicrobial effects of the...
4.
Yasar U, Demir Y, Gonul I, Ozaslan M, Celik G, Turkes C, et al.
Chem Biodivers
. 2024 Dec;
:e202402893.
PMID: 39654314
Sulfonate derivatives are an essential class of compounds with diverse pharmacological applications. This study presents the synthesis and detailed characterization of six novel Schiff base sulfonate derivatives (L-L) through spectroscopic...
5.
Erdogan M, Onder A, Demir Y, Comert Onder F
ACS Omega
. 2024 Dec;
9(47):46860-46878.
PMID: 39619510
The new dibenzoazepine-substituted triazole hybrids (-) were designed by molecular hybridization approach and synthesized utilizing the Cu(I)-catalyzed click reaction. The hybrid structures (-) were obtained in high yields (74-98%) with...
6.
Buza A, Turkes C, Arslan M, Demir Y, Dincer B, Nixha A, et al.
RSC Med Chem
. 2024 Nov;
PMID: 39493223
A series of sulfonamides incorporating a 1,2,3-triazolyloxime substituted 1,2,3-triazolyl moiety were conceptualized and synthesized as human carbonic anhydrase (CA) inhibitors. The synthesized small structures, denoted 7a through 7o, exhibited moderate...
7.
Bicer A, Caglayan C, Demir Y, Turkes C, Altundas R, Akyildiz H, et al.
Arch Biochem Biophys
. 2024 Sep;
761:110159.
PMID: 39322099
In this study, thiazole derivatives containing sulphonamide, amide, and phenyl amino groups were synthesized to protect the free amino groups of 5-methyl-4-phenyl-2-aminothiazole and 4-phenyl-2-aminothiazole. Halogenated reactions of N-protected thiazole derivatives...
8.
Kizir D, Yesilkent E, Ozturk N, Karagac M, Isiyel M, Tosun H, et al.
J Biochem Mol Toxicol
. 2024 Sep;
38(10):e23861.
PMID: 39305037
Doxorubicin (DOX) is an anthracycline antibiotic widely employed to treat carcinoma. Nevertheless, severe cardiotoxic side effects restrict its clinical use. Esculetin, a natural flavonoid, is found abundantly in plants. This...
9.
Ozturk N, Ceylan H, Demir Y
J Biochem Mol Toxicol
. 2024 Aug;
38(8):e23798.
PMID: 39108104
Doxorubicin (DOX), which is frequently used in cancer treatment, has limited clinical use due to adverse effects on healthy tissues, especially the liver. Therefore, it is necessary to research the...
10.
Gulec O, Turkes C, Arslan M, Isik M, Demir Y, Duran H, et al.
Arch Biochem Biophys
. 2024 Jul;
759:110099.
PMID: 39009270
In contemporary medicinal chemistry, employing a singular small molecule to concurrently multi-target disparate molecular entities is emerging as a potent strategy in the ongoing battle against metabolic disease. In this...